|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.027 HKD | +3.85% |
|
+17.39% | -50.91% |
| Mar. 28 | China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 15 | China NT Pharma Group Company Limited Announces Directorate Changes | CI |
China NT Pharma Group Company Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 120.5 million compared to CNY 111.23 million a year ago. Net loss was CNY 28.24 million compared to CNY 2.65 million a year ago.
Basic loss per share from continuing operations was CNY 0.0149 compared to CNY 0.0014 a year ago. Diluted loss per share from continuing operations was CNY 0.0149 compared to CNY 0.0014 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -50.91% | 8.77M | |
| +20.73% | 43.34B | |
| +20.44% | 21.96B | |
| +11.12% | 14.09B | |
| +11.95% | 13.64B | |
| +39.51% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
CHINA NT PHARMA GROUP COMPANY LIMITED 
